Latest news
SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger - StocktwitsStocktwits · Sat, 08 Aug 2026 22:18:38 GMTSLS Stock Tests $5 Again: Retail Targets ‘No’ Vote On 20M Share Dilution Push Before AML Trial Results - StocktwitsStocktwits · Sat, 08 Aug 2026 16:36:29 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 12:10:00 GMT